Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 15 studies | 52% ± 18% | |
| astrocyte | 12 studies | 33% ± 16% | |
| GABAergic neuron | 11 studies | 49% ± 20% | |
| microglial cell | 11 studies | 41% ± 14% | |
| glutamatergic neuron | 5 studies | 34% ± 13% | |
| retina horizontal cell | 5 studies | 46% ± 13% | |
| interneuron | 5 studies | 45% ± 24% | |
| endothelial cell of lymphatic vessel | 4 studies | 27% ± 6% | |
| type I pneumocyte | 4 studies | 23% ± 5% | |
| GABAergic interneuron | 3 studies | 59% ± 14% | |
| neuron | 3 studies | 29% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 29% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1730.20 | 2636 / 2642 | 99% | 59.86 | 701 / 705 |
| kidney | 71% | 212.91 | 63 / 89 | 19% | 1.60 | 169 / 901 |
| prostate | 29% | 66.86 | 72 / 245 | 34% | 0.55 | 173 / 502 |
| adrenal gland | 13% | 42.88 | 34 / 258 | 48% | 10.22 | 111 / 230 |
| pancreas | 3% | 5.46 | 10 / 328 | 53% | 2.27 | 95 / 178 |
| ovary | 3% | 4.46 | 5 / 180 | 51% | 3.36 | 219 / 430 |
| spleen | 44% | 91.83 | 106 / 241 | 0% | 0 | 0 / 0 |
| skin | 2% | 3.81 | 39 / 1809 | 31% | 2.02 | 146 / 472 |
| uterus | 15% | 38.38 | 25 / 170 | 14% | 0.72 | 66 / 459 |
| lung | 11% | 21.12 | 64 / 578 | 6% | 0.15 | 72 / 1155 |
| breast | 7% | 13.56 | 33 / 459 | 9% | 0.22 | 99 / 1118 |
| stomach | 2% | 3.08 | 7 / 359 | 13% | 0.33 | 37 / 286 |
| thymus | 10% | 16.66 | 64 / 653 | 3% | 0.18 | 20 / 605 |
| intestine | 3% | 4.81 | 27 / 966 | 4% | 0.13 | 22 / 527 |
| esophagus | 1% | 1.45 | 12 / 1445 | 6% | 0.14 | 11 / 183 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.19 | 5 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.41 | 2 / 45 |
| adipose | 4% | 6.86 | 46 / 1204 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 3% | 0.09 | 14 / 406 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.03 | 6 / 504 |
| blood vessel | 1% | 0.95 | 7 / 1335 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.16 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1901379 | Biological process | regulation of potassium ion transmembrane transport |
| GO_0071805 | Biological process | potassium ion transmembrane transport |
| GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0008076 | Cellular component | voltage-gated potassium channel complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0030425 | Cellular component | dendrite |
| GO_0005267 | Molecular function | potassium channel activity |
| GO_0015459 | Molecular function | potassium channel regulator activity |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0044325 | Molecular function | transmembrane transporter binding |
| Gene name | KCNIP1 |
| Protein name | Potassium voltage-gated channel interacting protein 1 Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1) (Vesicle APC-binding protein) |
| Synonyms | KCHIP1 VABP |
| Description | FUNCTION: Regulatory subunit of Kv4/D (Shal)-type voltage-gated rapidly inactivating A-type potassium channels. Regulates channel density, inactivation kinetics and rate of recovery from inactivation in a calcium-dependent and isoform-specific manner. In vitro, modulates KCND1/Kv4.1 and KCND2/Kv4.2 currents. Increases the presence of KCND2 at the cell surface. . |
| Accessions | ENST00000636734.1 ENST00000520740.5 [Q9NZI2-3] A0A1B0GTZ7 Q9NZI2 ENST00000517344.1 ENST00000377360.8 [Q9NZI2-4] ENST00000434108.5 [Q9NZI2-5] E5RJY5 ENST00000328939.9 [Q9NZI2-2] ENST00000411494.5 [Q9NZI2-1] |